New COVID-19 saliva-based test: How good is it compared with the current nasopharyngeal or throat swab test?

Kai Feng Hung, Yi Chen Sun, Bing Hong Chen, Jeng Fan Lo, Chao Min Cheng, Cho Yi Chen, Cheng Hsien Wu*, Shou Yen Kao

*此作品的通信作者

研究成果: Review article同行評審

36 引文 斯高帕斯(Scopus)

摘要

As of April 15, 2020, the US Food and Drug Administration has granted emergency use authorization to a first saliva test for diagnosis of severe acute respiratory syndrome coronavirus 2 infection, the device developed by RUCDR Infinite Biologics laboratory, Rutgers University. A key feature that distinguishes the saliva-based test from nasopharyngeal or oropharyngeal (throat) swabs is that this kit allows self-collection and can spare healthcare professionals to be at risk during collecting nasopharyngeal or oropharyngeal samples, thereby preserving personal protective equipment for use in patient care rather than sampling and testing. Consequently, broader testing than the current methods of nasal or throat swabs will significantly increase the number of people screening, leading to more effective control of the spread of COVID-19. Nonetheless, a comparison of saliva-based assay with current swab test is needed to understand what and how we can benefit from this newly developed assay. Therefore, in this mini-review article, we aimed to summarize the current and emerging tools, focusing on diagnostic power of different clinical sampling and specimens.

原文English
頁(從 - 到)891-894
頁數4
期刊Journal of the Chinese Medical Association
83
發行號10
DOIs
出版狀態Published - 10月 2020

指紋

深入研究「New COVID-19 saliva-based test: How good is it compared with the current nasopharyngeal or throat swab test?」主題。共同形成了獨特的指紋。

引用此